{"id":"W2397716952","doi":"10.1016/j.jval.2016.03.1611","title":"Cost-Effectiveness of Pembrolizumab (Keytruda®) Versus Ipilimumab in Patients with Advanced Melanoma in Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Merck Canada Inc. (Canada); Université de Montréal","funders":"","keywords":"Ipilimumab; Pembrolizumab; Medicine; Clinical trial; Internal medicine; Oncology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004149946,0.0001290225,0.0004171668,0.0001830785,0.00001343837,0.000001319638,0.00007490274,0.00004271926,0.00002158679],"category_scores_gemma":[0.00006029025,0.0000886054,0.00002359581,0.000407989,0.00004203517,0.0000609989,0.00001314375,0.0001135576,7.377526e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004106025,"about_ca_system_score_gemma":0.00318527,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8303211,"about_ca_topic_score_gemma":0.7156386,"domain_scores_codex":[0.998466,0.0002519158,0.0004183027,0.0002396483,0.0002744382,0.0003497242],"domain_scores_gemma":[0.999134,0.0003730368,0.0001325292,0.0002348388,0.00004409161,0.00008150359],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06862693,0.000226625,0.8719839,0.0004411525,0.000022782,0.00001781915,0.0001516334,0.0002108972,0.0001820692,0.00002604118,0.00001574965,0.05809441],"study_design_scores_gemma":[0.05547087,0.001879409,0.9392464,0.002224045,0.000002969196,0.000001460082,0.00009053541,0.00003504645,0.0006592566,0.00001005487,0.0002793293,0.0001006105],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973848,0.000532516,0.000005060144,0.0003268856,0.000267102,0.001326927,0.00003019412,0.000006138533,0.0001203247],"genre_scores_gemma":[0.9995682,0.0001690233,0.00005719615,0.0000990765,0.000008699887,0.00006399521,0.000009813754,0.00001706638,0.000006914202],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1146825,"threshold_uncertainty_score":0.9997171,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02885874383603323,"score_gpt":0.2887272278546563,"score_spread":0.2598684840186231,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}